| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 30 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.51M | $50.73M | - | |
| 10% | 6.46M | $24.26M | - | |
| Other | 146.5K | $550.1K | - | |
| Other | 100.0K | $375.5K | - | |
| CEO | 79.1K | $297.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2020 | Sun Anthony Y81 | President &CEO | Sell | 26,794 | $51.40 | $1,377,343.68 | -0.3% | |
| Dec 2, 2020 | Epperly Melissa B,72 | Chief Financial Officer | Sell | 3,083 | $51.47 | $158,680.78 | -0.3% | |
| Dec 2, 2020 | Johnson David Michael59 | Director | Sell | 12,896 | $51.39 | $662,746.59 | -2.9% | |
| Dec 1, 2020 | Bunker Kevin D.78 | Chief Operating Officer | Sell | 8,420 | $52.96 | $445,883.33 | -1.9% | |
| Dec 1, 2020 | Viking Global Investors LP66 | 10% Owner | Sell | 500,000 | $50.50 | $25,250,000.00 | -11.3% | |
| Nov 24, 2020 | Sun Anthony Y81 | President &CEO | Sell | 26,794 | $46.49 | $1,245,764.25 | -0.3% | |
| Nov 23, 2020 | Gallagher Cam81 | Director | Sell | 10,000 | $46.54 | $465,381.07 | -0.8% | |
| Nov 23, 2020 | Epperly Melissa B,72 | Chief Financial Officer | Sell | 3,083 | $46.58 | $143,613.51 | -0.5% | |
| Nov 23, 2020 | Bunker Kevin D.78 | Chief Operating Officer | Sell | 8,425 | $46.55 | $392,178.95 | -2.9% | |
| Apr 7, 2020 | Johnson David Michael59 | Director | Buy | 4,000 | $18.00 | $72,000.00 | +3.6% |